–
Gyre Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
97.5
FY23:
109
FY24:
102
FY25:
111
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.9
FY22:
9.20
FY23:
−67.2
FY24:
12.3
FY25:
6.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.9
FY22:
9.41
FY23:
−77.0
FY24:
23.2
FY25:
14.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.9
FY22:
4.31
FY23:
−85.5
FY24:
17.9
FY25:
9.88
All amounts in millions USD